Ariad Pharmaceuticals - der letzte Thread
Seite 101 von 196 Neuester Beitrag: 25.04.21 00:38 | ||||
Eröffnet am: | 19.09.11 13:39 | von: steven-bln | Anzahl Beiträge: | 5.875 |
Neuester Beitrag: | 25.04.21 00:38 | von: Andreadhata | Leser gesamt: | 540.481 |
Forum: | Hot-Stocks | Leser heute: | 322 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 98 | 99 | 100 | | 102 | 103 | 104 | ... 196 > |
2 Sen Das Oma und Opa noch ne Gans für Weihnachten kaufen wollen und brauchen die Paar Doller die in ariad stecken ;-)
3 Sen relativ unwahrscheinlich das negativ News kommen und ein paar von wissen
In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Ariad Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
However, some better performing stocks in the biopharmaceutical industry include Heska Corporation ( HSKA ), Actelion Ltd. ( ALIOF ) and Jazz Pharmaceuticals plc ( JAZZ ), all with a Zacks Rank #1 (Strong Buy).
Read more: http://www.nasdaq.com/article/...e-of-the-tape-cm312520#ixzz2nvf54UHg
##################################################
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), percentage change surged19.71% to close at $4.98 with the total traded volume of 45.90 million shares, more than average volume of 20.76 million. The 52 week range of the stock remained $2.15 – $23.00, while its day lowest price was $4.11 and it hit its day highest price at $5.04.
ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients.
Und die wollen was über Ariad Schreiben. Da kann es ja mit der Info nicht zu weit her sein.